These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29878618)

  • 1. Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital.
    Suda M; Suyama Y; Ohde S; Tsuda T; Sawada H; Kishimoto M; Okada M
    Int J Rheum Dis; 2018 May; 21(5):975-981. PubMed ID: 29878618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
    Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A
    Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).
    Majumdar SR; Lix LM; Yogendran M; Morin SN; Metge CJ; Leslie WD
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1236-42. PubMed ID: 22298803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced osteoporosis preventive care in rheumatology patients.
    Koller G; Katz S; Charrois TL; Ye C
    Arch Osteoporos; 2019 Feb; 14(1):16. PubMed ID: 30723883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial.
    Klop C; de Vries F; Vinks T; Kooij MJ; van Staa TP; Bijlsma JW; Egberts AC; Bouvy ML
    Osteoporos Int; 2014 Jan; 25(1):385-92. PubMed ID: 24221450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
    Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
    Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
    Buckley L; Guyatt G; Fink HA; Cannon M; Grossman J; Hansen KE; Humphrey MB; Lane NE; Magrey M; Miller M; Morrison L; Rao M; Robinson AB; Saha S; Wolver S; Bannuru RR; Vaysbrot E; Osani M; Turgunbaev M; Miller AS; McAlindon T
    Arthritis Rheumatol; 2017 Aug; 69(8):1521-1537. PubMed ID: 28585373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan.
    Chitre MM; Hayes W
    J Manag Care Pharm; 2008 Apr; 14(3):281-90. PubMed ID: 18439050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
    Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
    Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.
    Sato H; Kondo N; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
    Rheumatol Int; 2019 Oct; 39(10):1803-1810. PubMed ID: 31385078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-Induced Osteoporosis Prevention in Polymyalgia Rheumatica Patients.
    Swami T; Molloy C
    Ir Med J; 2020 Mar; 113(3):36. PubMed ID: 32815678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
    Suzuki Y; Sato S
    Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy.
    Sadat-Ali M; Alelq AH; Alshafei BA; Al-Turki HA; Abujubara MA
    Ann Saudi Med; 2009; 29(3):215-8. PubMed ID: 19448373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E; Walker-Bone K
    QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
    Lee JH; Cho SK; Han M; Kim D; Bae SC; Sung YK
    Korean J Intern Med; 2014 Jul; 29(4):509-15. PubMed ID: 25045299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis].
    Tanaka I
    Clin Calcium; 2014 Sep; 24(9):1371-8. PubMed ID: 25177010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
    Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
    Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis].
    Kaneko K; Kawai S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(3):138-48. PubMed ID: 21720102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.